期刊文献+

血清尿酸、胱抑素C、NT-pro-BNP及PCT表达水平与CHF并发医院感染患者预后的关系 被引量:7

Analysis of relationship between expression levels of serum uric acid,cystatin C,NT-pro-BNP and PCT and prognosis of patients with chronic heart failure complicated with nosocomial infection
原文传递
导出
摘要 目的探讨血清尿酸、胱抑素C(Cys C)、N末端B型利钠肽前体(NT-pro-BNP)及降钙素原(PCT)表达水平与慢性心力衰竭(CHF)并发医院感染患者预后的关系。方法回顾性分析2017年1月-2019年2月东方医院收治的224例CHF住院患者,其中并发医院感染患者110例(感染组),单纯慢性心力衰竭患者114例(未感染组),采用酶联免疫吸附法检测血清尿酸、PCT、NT-pro-BNP、Cys C,住院期间及出院后3个月内发生不良心脏事件(MACE)为预后不良,分析影响CHF并发医院感染患者预后的危险因素,应用受试者工作特征曲线(ROC)和曲线下面积(AUC)分析尿酸、Cys C、NT-pro-BNP、PCT单独检测和四项联合对CHF并发医院感染患者预后的预测价值。结果感染组CHF患者血清尿酸、Cys C、NT-pro-BNP、PCT均显著高于未感染组,差异有统计学意义(P<0.05)。感染组预后不良率为38.18%(42/110),显著高于未感染组的20.18%(23/114),差异有统计学意义(P<0.05)。感染组预后不良者血清尿酸、Cys C、NT-pro-BNP、PCT均显著高于预后良好者,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,美国纽约心脏协会(NYHA)分级、尿酸、Cys C、NT-pro-BNP、PCT是影响CHF并发医院感染患者预后独立危险因素(P<0.05)。四项联合预测CHF并发医院感染患者预后的AUC大于单独检测及两项联合检测。结论血清尿酸、Cys C、NT-pro-BNP、PCT可用于CHF并发医院感染患者的预后评估,四项联合检测的预测效能更优。 Objective To investigate the relationship between expression levels of serum uric acid,cystatin C(Cys C),Nterminal pro-brain natriuretic peptide(NT-pro-BNP)and procalcitonin(PCT)and prognosis of patients with chronic heart failure(CHF)complicated with nosocomial infection.Methods A retrospective analysis was performed on 224 inpatients with CHF admitted from January 2017 to February 2019,including 110 patients complicated with nosocomial infection(infected group)and 114 patients with simple chronic heart failure(uninfected group).The levels of serum uric acid,PCT,NT-pro-BNP and Cys C were detected by enzyme linked immunosorbent assay.The occurrence of major adverse cardiac events(MACE)during hospitalization and within 3 months after discharge was set as poor prognosis.The risk factors that affected prognosis of patients with CHF complicated with nosocomial infection were analyzed.The receiver operating characteristic curve(ROC)and the area under the curve(AUC)were used to analyze the predictive value of uric acid,Cys C,NT-pro-BNP,and PCT and combination of the four on the prognosis of patients with CHF complicated with nosocomial infection.Results The levels of serum uric acid,Cys C,NT-pro-BNP and PCT in infected group were significantly higher than those in uninfected group(P<0.05).The poor prognosis rate in infected group was significantly higher than that in uninfected group[38.18%(42/110)vs.20.18%(23/114)](P<0.05).The levels of serum uric acid,Cys C,NT-pro-BNP and PCT of patients with poor prognosis in infected group were significantly higher than those in patients with good prognosis(P<0.05).Multivariate Logistic regression analysis showed that New York heart association(NYHA)classification,uric acid,Cys C,NT-pro-BNP and PCT were independent risk factors affecting the prognosis of patients with CHF complicated with nosocomial infection(P<0.05).The AUC of combination of the four was greater than those of separate detection or two combined detection in predicting the prognosis of patients with CHF complicated with nosocomial infection.Conclusions Serum uric acid,Cys C,NT-pro-BNP and PCT could be used to evaluate the prognosis of patients with CHF complicated with nosocomial infection.The combination of the four had better predictive efficacy.
作者 张子豪 王昌生 尹纪来 钟业腾 黎雄 吉艳妮 ZHANG Zi-hao;WANG Chang-sheng;YIN Ji-lai;ZHONG Ye-teng;LI Xiong;JI Yan-ni(Dongfang Hospital of Dongfang city,Dongfang,Hainan 572600;The First Affiliated Hospital of Hainan Medical University,Haikou,Hainan 570102;The Second Affiliated Hospital of Hainan Medical University,Haikou,Hainan 570216,China)
出处 《热带医学杂志》 CAS 2021年第8期1006-1010,1092,共6页 Journal of Tropical Medicine
基金 海南省重点研发计划项目(ZDYF2016224)
关键词 尿酸 胱抑素C N末端B型利钠肽前体 降钙素原 慢性心力衰竭 Uric acid Cystatin C N-terminal pro-brain natriuretic peptide Procalcitonin Chronic heart failure
  • 相关文献

参考文献13

二级参考文献117

  • 1兰信国,吴秀华.C反应蛋白的临床应用评价[J].健康大视野(医学版),2006,14(4):48-49. 被引量:4
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.

共引文献9558

同被引文献96

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部